RxDoctor Payments Data

Carie Johnson, APRN

Family · Circleville, OHNPI 1003351024

Payments from drug & device makers

$399in general payments, 2019–2025

Across 20 payments — averaging $19.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Exact Sciences$86
  • AbbVie$83
  • Lilly USA, LLC$82
  • Novo Nordisk$51
  • AstraZeneca$30
  • Biohaven Pharmaceuticals, Inc.$23
  • plus $46 from 3 others

What the payments were for

  • Food & beverage$35489%
  • Education$4511%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$399 in reported general payments places this provider in the 50th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$19,537
Medicare patients
142
Services billed
464

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide41$52,588
OzempicSemaglutide49$43,255
XifaxanRifaximin12$38,530
EliquisApixaban49$37,569
TrulicityDulaglutide26$30,497
JardianceEmpagliflozin30$23,758
Tresiba Flextouch U-200Insulin Degludec13$12,745
Breztri AerosphereBudesonide/Glycopyr/Formoterol11$11,136
Breo ElliptaFluticasone/Vilanterol16$7,714
Stiolto RespimatTiotropium Br/Olodaterol Hcl11$7,152
SymbicortBudesonide/Formoterol Fumarate20$5,448
Fluticasone Propionate HfaFluticasone Propionate11$3,998
Varenicline Tartrate16$3,385
Albuterol Sulfate HfaAlbuterol Sulfate100$3,241
Lantus SolostarInsulin Glargine,hum.Rec.Anlog22$2,825

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$82$83,08567 claims
Novo NordiskOzempic$51$43,25549 claims
PfizerEliquis$12$37,56949 claims
AstraZenecaBreztri Aerosphere, Symbicort$30$16,58431 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 6,812 family providers in Ohio.

Other family in Circleville

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →